Literature DB >> 34136958

Substitution of ROTEM FIBTEM A5 for A10 in trauma: an observational study building a case for more rapid analysis of coagulopathy.

Alexander Blayney1, James McCullough2, Elizabeth Wake3, Kerin Walters2, Don Campbell3, Debbie Ho2, Erick Chan2, Aashish Chalasani2, James Winearls2,4,5,6.   

Abstract

PURPOSE: Rotational thromboelastometry (ROTEM®) allows guided blood product resuscitation to correct trauma-induced coagulopathy in bleeding trauma patients. FIBTEM amplitude at 10 min (A10) has been widely used to identify hypofibrinogenaemia; locally a threshold of < 11 mm has guided fibrinogen replacement. Amplitude at 5 min (A5) carries an inherent time advantage. The primary aim was to explore the relationship between FIBTEM A5 and A10 in a trauma. Secondary aim was to investigate the use of A5 as a surrogate for A10 within a fibrinogen-replacement algorithm.
METHODS: Retrospective observational cohort study of arrival ROTEM results from 1539 consecutive trauma patients at a Level 1 trauma centre in Australia. Consistency of agreement between FIBTEM A5 and A10 was assessed. A new fibrinogen replacement threshold was developed for A5 using the A5-A10 bias; this was clinically compared to the existing A10 threshold.
RESULTS: FIBTEM A5 displayed excellent consistency of agreement with A10. Intraclass correlation coefficient = 0.972 (95% confidence interval [CI] 0.969-0.974). Bias of A5 to A10 was - 1.49 (95% CI 1.43-1.56) mm. 19.34% patients met the original local threshold of A10 < 11 mm; 19.28% patients met the new, bias-adjusted threshold of A5 < 10 mm.
CONCLUSION: ROTEM FIBTEM A5 reliably predicts A10 in trauma. This further validates use of the A5 result over A10 allowing faster decision-making in time-critical resuscitation of trauma patients. A modification of -1 to the A10 threshold might be appropriate for use with the A5 value in trauma patients.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Coagulopathy; Fibrinogen; Haemorrhage; ROTEM; Resuscitation; Rotational thromboelastometry; Trauma

Mesh:

Substances:

Year:  2021        PMID: 34136958     DOI: 10.1007/s00068-021-01652-w

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  1 in total

1.  Targeted fibrinogen concentrate use in severe traumatic haemorrhage.

Authors:  Jacqueline A Seebold; Don Campbell; Elizabeth Wake; Kerin Walters; Debbie Ho; Erick Chan; Andrew C Bulmer; Martin Wullschleger; James Winearls
Journal:  Crit Care Resusc       Date:  2019-09       Impact factor: 2.159

  1 in total
  1 in total

1.  Which injured patients with moderate fibrinogen deficit need fibrinogen supplementation?

Authors:  Jean-Stephane David; Aline Lambert; Xavier-Jean Taverna; Pascal Incagnoli; Marie-Odile Geay-Baillat; Olivia Vassal; Arnaud Friggeri; Kenji Inaba
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-12-24       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.